Houston drug injury lawyers: Samantha Lynn Inc. has voluntarily recalled 500 lots of its Reumofan Plus Tablets due to a finding by the U.S. FDA of undeclared ingredients in the drug. The undeclared ingredients could cause dangerous allergic reactions in users that could lead to serious complications and even death.
The Samantha Lyn Reumofan Plus Tablets were found after FDA analysis to contain methocarbamol and diclofenac. These undeclared ingredients could lead to life-threatening hypersensitivity reactions as well as anaphylaxis. They undeclared ingredients could also lead to temporary and reversible increases in CNS depression.
The multi-purpose drug is used to prevent kidney transplant rejection and as a treatment for bone cancer, muscle pain, arthritis, osteoporosis, and other conditions. Our Houston drug injury lawyers point out that the recalled Reumofan Plus Tablets expire in 2016 and have the lot number 99515 ex096. The tablets generally come in set of 30 round lavender tablets in a green bottle and are distributed via the Internet.
If you purchased Reumofan Plus from Samantha Lynn Inc. between Feb 2012 and June
2012, you should receive an email notifying you of your options. If you purchased Reumofan Plus from elsewhere such as via the Internet, you could contact your local FDA office for information. If you possess some Reumofan Plus Tablets, you should be aware that the defective product with its undeclared ingredients might pose a serious, even fatal, health. So stop using the product immediately. Contact your physician or healthcare provider if they have any health questions.
And if you or a loved one have experienced any problems like life threatening allergic reactions that may be related to taking or using this product, contact our Houston drug injury lawyers for a free consultation regarding your injury. We could help you protect your rights in the matter and advise you regarding your important legal options for winning full financial compensation for your harm from the dangerous and defective product.